Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback